Blunting specific T-dependent antibody responses with engineered "decoy" B cells.

MLA

Pitner, Ragan A., et al. “Blunting Specific T-Dependent Antibody Responses with Engineered ‘Decoy’ B Cells.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 32, no. 10, Oct. 2024, pp. 3453–69. EBSCOhost, https://doi.org/10.1016/j.ymthe.2024.08.023.

APA

Pitner, R. A., Chao, J. L., Dahl, N. P., Fan, M.-N., Cai, X., Avery, N. G., Roe, K., Spiegel, P. C., Jr, Miao, C. H., Gerner, M. Y., James, R. G., & Rawlings, D. J. (2024). Blunting specific T-dependent antibody responses with engineered “decoy” B cells. Molecular Therapy : The Journal of the American Society of Gene Therapy, 32(10), 3453–3469. https://doi.org/10.1016/j.ymthe.2024.08.023

Chicago

Pitner, Ragan A, Jaime L Chao, Noelle P Dahl, Meng-Ni Fan, Xiaohe Cai, Nathan G Avery, Kelsey Roe, et al. 2024. “Blunting Specific T-Dependent Antibody Responses with Engineered ‘Decoy’ B Cells.” Molecular Therapy : The Journal of the American Society of Gene Therapy 32 (10): 3453–69. doi:10.1016/j.ymthe.2024.08.023.